FibroGen, Inc.FGENNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
55.10%
↑ 371% above average
Average (39q)
-20.35%
Historical baseline
Range
High:330.98%
Low:-446.29%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 55.10% |
| Q2 2025 | 19.22% |
| Q1 2025 | 83.72% |
| Q4 2024 | -446.29% |
| Q3 2024 | 63.85% |
| Q2 2024 | 5.64% |
| Q1 2024 | 9.25% |
| Q4 2023 | 14.63% |
| Q3 2023 | 27.90% |
| Q2 2023 | -15.71% |
| Q1 2023 | -15.02% |
| Q4 2022 | 29.37% |
| Q3 2022 | -19.73% |
| Q2 2022 | -24.18% |
| Q1 2022 | 53.42% |
| Q4 2021 | -365.31% |
| Q3 2021 | 138.09% |
| Q2 2021 | -90.03% |
| Q1 2021 | -21.43% |
| Q4 2020 | -279.39% |
| Q3 2020 | 137.97% |
| Q2 2020 | -5.01% |
| Q1 2020 | 19.28% |
| Q4 2019 | -90.03% |
| Q3 2019 | -146.85% |
| Q2 2019 | 330.98% |
| Q1 2019 | -345.21% |
| Q4 2018 | 146.57% |
| Q3 2018 | -84.04% |
| Q2 2018 | 42.75% |
| Q1 2018 | -70.51% |
| Q4 2017 | 33.89% |
| Q3 2017 | -14.67% |
| Q2 2017 | -0.12% |
| Q1 2017 | -0.29% |
| Q4 2016 | -41.53% |
| Q3 2016 | -183.37% |
| Q2 2016 | 198.98% |
| Q1 2016 | 44.71% |
| Q4 2015 | -10.69% |